Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome
18 May 2016 | By Mandy Parrett, Editorial Assistant
Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.